Kuwait's Twice-Struck Desalination Plant Raises Questions About Regional Pharma Manufacturing Water Supply

Introduction

The reported damage to a desalination plant in Kuwait for the second time has renewed concerns about the resilience of critical infrastructure supporting the Gulf's pharmaceutical manufacturing sector. While desalination facilities are primarily associated with providing drinking water, they also play a vital role in supplying industrial-grade water used across pharmaceutical, biotechnology, and chemical manufacturing operations.

For pharmaceutical manufacturers operating in the Gulf Cooperation Council (GCC) region, repeated disruptions to water infrastructure highlight an often-overlooked supply chain risk. Water availability is fundamental to the production of Active Pharmaceutical Ingredients (APIs), sterile injectables, biologics, and high-purity excipients. Any prolonged interruption could have operational, regulatory, and financial implications for manufacturers and their global customers.

Why Water Security Matters for Pharmaceutical Manufacturing

Water is one of the most critical raw materials in pharmaceutical production. High-purity water systems—including Purified Water (PW) and Water for Injection (WFI)—are essential for manufacturing, cleaning, equipment sterilization, formulation, and quality control.

Pharmaceutical facilities depend on consistent water supplies for:

• API synthesis and processing.

• Production of sterile injectables.

• Biologics and vaccine manufacturing.

• Equipment cleaning and sanitation.

• Laboratory testing and quality assurance.

• HVAC and cooling systems supporting production environments.

Even temporary interruptions can slow production schedules and require extensive validation before operations resume.

The Gulf's Dependence on Desalination

Unlike many manufacturing regions that rely on freshwater rivers or groundwater, Gulf countries depend heavily on seawater desalination to meet municipal and industrial demand.

This dependence means that disruptions to desalination infrastructure may affect:

• Industrial water availability.

• Manufacturing continuity.

• Utility reliability.

• Operational planning.

• Emergency resource allocation.

For pharmaceutical manufacturers, water security has become an essential component of business continuity planning.

Potential Impacts on Regional Pharmaceutical Production

If water infrastructure disruptions become prolonged or widespread, pharmaceutical manufacturers may face several operational challenges.

Potential impacts include:

• Reduced manufacturing capacity.

• Delays in API production.

• Temporary shutdowns for maintenance or water conservation.

• Increased operating costs associated with alternative water sources.

• Longer lead times for finished pharmaceutical products.

Facilities producing high-value medicines or sterile products may be particularly vulnerable due to their stringent water quality requirements.

Broader Supply Chain Implications

The implications extend beyond pharmaceutical manufacturers. Companies sourcing raw materials or finished medicines from the Gulf region could experience indirect supply chain effects.

Industries that may be affected include:

• Active Pharmaceutical Ingredients (APIs)

• Biologics

• Sterile injectables

• Specialty chemicals

• Laboratory reagents

• Medical device manufacturing

• Healthcare distribution networks

Although no widespread production disruptions may occur immediately, infrastructure resilience has become an increasingly important procurement consideration.

Risk Mitigation Strategies for Manufacturers

To strengthen operational resilience, pharmaceutical companies should evaluate infrastructure-related risks alongside traditional supplier assessments.

Recommended actions include:

Assess Utility Dependencies

Understand supplier reliance on regional water, electricity, and critical infrastructure.

Strengthen Business Continuity Planning

Develop contingency procedures for utility disruptions affecting manufacturing operations.

Diversify Manufacturing Footprints

Reduce dependence on a single production location for strategically important products.

Maintain Strategic Safety Stocks

Build appropriate inventory levels for critical APIs and finished medicines to absorb temporary production interruptions.

Monitor Infrastructure Risks

Incorporate geopolitical and infrastructure intelligence into procurement and supply chain risk monitoring.

What Procurement Leaders Should Watch

As regional infrastructure risks evolve, procurement teams should monitor:

• Desalination plant operational status.

• Utility reliability across Gulf manufacturing hubs.

• Pharmaceutical production capacity updates.

• Water-related regulatory developments.

• Supplier business continuity measures.

• Lead-time changes for critical pharmaceutical ingredients.

Proactive monitoring enables organizations to respond before localized disruptions affect global supply chains.

Conclusion

The repeated impact on Kuwait's desalination infrastructure serves as a reminder that water security is becoming an increasingly important consideration for pharmaceutical manufacturing resilience. In regions where desalination underpins industrial activity, protecting critical water infrastructure is essential to maintaining stable production and uninterrupted medicine supply.

For procurement, operations, and supply chain leaders, infrastructure resilience should now be evaluated alongside traditional sourcing metrics such as cost, quality, and supplier reliability. Organizations that incorporate utility risk, diversified manufacturing, and real-time infrastructure monitoring into their procurement strategies will be better equipped to navigate future disruptions in an increasingly interconnected pharmaceutical supply chain.